NanoViricides, Inc. (NNVC)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 09, 13:58
NanoViricides Price to Book Value : 2.578 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.554 |
| September 04, 2026 | 2.649 |
| September 03, 2026 | 2.720 |
| September 02, 2026 | 2.767 |
| September 01, 2026 | 2.862 |
| August 31, 2026 | 2.956 |
| August 28, 2026 | 2.932 |
| August 27, 2026 | 3.027 |
| August 26, 2026 | 3.027 |
| August 25, 2026 | 3.051 |
| August 24, 2026 | 3.003 |
| August 21, 2026 | 3.145 |
| August 20, 2026 | 3.098 |
| August 19, 2026 | 3.169 |
| August 18, 2026 | 3.192 |
| August 17, 2026 | 3.216 |
| August 14, 2026 | 3.264 |
| August 13, 2026 | 3.216 |
| August 12, 2026 | 3.240 |
| August 11, 2026 | 3.216 |
| August 10, 2026 | 3.311 |
| August 07, 2026 | 3.358 |
| August 06, 2026 | 3.311 |
| August 05, 2026 | 3.382 |
| August 04, 2026 | 3.595 |
| Date | Value |
|---|---|
| August 03, 2026 | 3.666 |
| July 31, 2026 | 3.595 |
| July 30, 2026 | 3.666 |
| July 29, 2026 | 3.642 |
| July 28, 2026 | 3.807 |
| July 27, 2026 | 3.642 |
| July 24, 2026 | 3.50 |
| July 23, 2026 | 3.618 |
| July 22, 2026 | 3.595 |
| July 21, 2026 | 3.784 |
| July 20, 2026 | 4.138 |
| July 17, 2026 | 4.138 |
| July 16, 2026 | 4.186 |
| July 15, 2026 | 4.068 |
| July 14, 2026 | 4.186 |
| July 13, 2026 | 3.902 |
| July 10, 2026 | 3.571 |
| July 09, 2026 | 3.807 |
| July 08, 2026 | 3.666 |
| July 07, 2026 | 3.476 |
| July 06, 2026 | 3.547 |
| July 02, 2026 | 3.145 |
| July 01, 2026 | 3.192 |
| June 30, 2026 | 3.264 |
| June 29, 2026 | 3.240 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.669 |
| Alnylam Pharmaceuticals, Inc. | 25.18 |
| Anika Therapeutics, Inc. | 2.037 |
| Savara, Inc. | 7.728 |
| Vericel Corp. | 5.364 |
Price to Book Value Related Metrics
| Price | 1.09 |
| Earnings Yield | -39.94% |
| Market Cap | 23.59M |